Csaba Fehér
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 3
- Virology 4
- HIV Research and Treatment 4
- Co-authors
- Àlex SorianoJosep MensaFrancesc MarcoLaura MorataJosé Antonio MartínezOlga Rodríguez-NúñezCelia CardozoCarolina García‐Vidal
- Journals
- Infectious Diseases and Therapy (4 papers)Clinical Microbiology and Infection (2 papers)Vaccines (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)
- Partner nations
- SpainItalyNetherlands
In The Last Decade
Csaba Fehér
23 papers receiving 477 citations
Peers
Comparison fields: 5 of 70
- Applied Microbiology and Biotechnology 104
- Molecular Medicine 180
- Clinical Biochemistry 96
- Pharmacology 157
- Infectious Diseases 119
Countries citing papers authored by Csaba Fehér
This map shows the geographic impact of Csaba Fehér's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Csaba Fehér with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Csaba Fehér more than expected).
Fields of papers citing papers by Csaba Fehér
This network shows the impact of papers produced by Csaba Fehér. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Csaba Fehér. The network helps show where Csaba Fehér may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Csaba Fehér, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 2 | |
| 2 | 2021 | 2 | |
| 3 | 2020 | 25 | |
| 4 | 2020 | 13 | |
| 5 | 2019 | 29 | |
| 6 | 2019 | 18 | |
| 7 | 2019 | 5 | |
| 8 | 2018 | 44 | |
| 9 | 2018 | 63 | |
| 10 | 2018 | 32 | |
| 11 | 2018 | 4 | |
| 12 | 2017 | 18 | |
| 13 | 2016 | 20 | |
| 14 | 2016 | 12 | |
| 15 | 2016 | 29 | |
| 16 | 2016 | 20 | |
| 17 | 2014 | 36 | |
| 18 | 2014 | 38 | |
| 19 | 2014 | 18 | |
| 20 | Aspergillus endocarditis following aortic valve replacement. | 1973 | 1 |
About Csaba Fehér
Csaba Fehér is a scholar working on Applied Microbiology and Biotechnology, Virology, Molecular Medicine, Infectious Diseases and Clinical Biochemistry, having authored 23 papers that have together received 482 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (7 papers), HIV Research and Treatment (4 papers), Antibiotic Resistance in Bacteria (4 papers), Bacterial Identification and Susceptibility Testing (4 papers), Gut microbiota and health (4 papers), Gastrointestinal motility and disorders (3 papers), Antibiotic Use and Resistance (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (104 citations), Molecular Medicine (180 citations), Clinical Biochemistry (96 citations), Pharmacology (157 citations) and Infectious Diseases (119 citations). Csaba Fehér has collaborated with scholars based in Spain, Italy and Netherlands. Frequent co-authors include Àlex Soriano, Josep Mensa, Francesc Marco, Laura Morata, José Antonio Martínez, Olga Rodríguez-Núñez, Celia Cardozo, Carolina García‐Vidal, Ana del Rı́o and Pedro Puerta‐Alcalde. Their work appears in journals such as Infectious Diseases and Therapy, Clinical Microbiology and Infection, Vaccines, European Journal of Clinical Microbiology & Infectious Diseases and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.